Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1]. Group 1: Allegations of Fraud - The lawsuit claims that Perrigo's acquisition of the infant formula business from Nestlé was significantly underinvested in maintenance and operational improvements [2]. - It is alleged that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated cost estimates to address issues in the infant formula business [2]. - The complaint points out significant manufacturing deficiencies in the facility related to the infant formula business [2]. - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were reportedly overstated [2]. - The lawsuit asserts that the positive statements made by the defendants regarding Perrigo's business and prospects were materially misleading and lacked a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until January 16, 2026, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Stride, Inc. ("Stride" or the "Company") (NYSE: LRN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Stride investors who were adversely affected by alleged securities fraud between October 22, 2024 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/stride-inc-lawsuit-submission-form ...

Core Viewpoint - A class action securities lawsuit has been filed against Integer Holdings Corporation, alleging securities fraud that affected investors between July 25, 2024, and October 22, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Integer Holdings Corporation materially overstated its competitive position in the electrophysiology manufacturing market [2]. - It is alleged that despite claims of strong visibility into customer demand, the company was experiencing a sustained deterioration in sales related to two of its electrophysiology devices [2]. - The complaint further asserts that Integer mischaracterized its electrophysiology devices as a long-term growth driver for its cardio & vascular segment, leading to materially false and misleading statements about the company's business and prospects [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the relevant time frame have until February 9, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a track record of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - Varonis Systems, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 4, 2025, and October 28, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Varonis provided overly positive statements while concealing material adverse facts about its ability to convert its customer base, leading to reduced Annual Recurring Revenue (ARR) growth potential [2] - On October 28, 2025, Varonis reported third-quarter financial results that significantly missed ARR expectations and lowered its full-year guidance, attributing this to weaker than expected renewals and conversions in its subscription business [2] - Following the announcement, Varonis' stock price plummeted from $63.00 per share to $32.34 per share, a decline of approximately 48.67% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the relevant time frame have until March 9, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for misrepresentations regarding its accounts receivable during the Class Period from July 18, 2024, to November 12, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Ardent Health made false statements about its accounts receivable management, including the reliance on "detailed reviews of historical collections" and the adequacy of its professional malpractice liability insurance [5]. - Defendants allegedly downplayed the issue of increased claim denials by third-party payors, misrepresenting the situation as a "slow pay" issue rather than acknowledging uncollectible accounts [5]. - The lawsuit asserts that Ardent Health's accounts receivable framework allowed for inflated reporting, delaying the recognition of losses on uncollectible accounts [5]. Group 2: Investor Information - Investors who purchased Ardent Health securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm for more information [3][6]. - A lead plaintiff must be appointed by March 9, 2026, to represent the interests of other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with notable achievements in previous years [4].

Core Viewpoint - The SLM Corporation, also known as Sallie Mae, is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements regarding delinquency rates in private education loans [1][3]. Group 1: Class Action Details - Investors in SLM securities from July 25, 2025, to August 14, 2025, can seek appointment as lead plaintiff by February 17, 2026 [1]. - The lawsuit is titled Zappia v. SLM Corporation and is filed in the District of New Jersey [1]. - The allegations include that SLM experienced a significant increase in early-stage delinquencies, which was not disclosed to investors [3]. Group 2: Financial Impact - A report from TD Cowen indicated that July 2025 delinquencies increased by 49 basis points month-over-month, which was worse than the seasonal average increase of 10 basis points [4]. - This report contradicted statements made by SLM's CFO, who claimed delinquency rates were following normal seasonal trends [4]. - Following the release of this report, SLM's stock price fell by approximately 8% [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who invested in SLM securities during the class period to seek lead plaintiff status [5]. - The lead plaintiff represents the interests of all class members and can select a law firm for litigation [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in securing monetary relief for investors in four out of the last five years [6].

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Ardent Health, Inc. ("Ardent†or the "Company†) (NYSE: ARDT) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ARDENT HEALTH, INC. (ARDT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 12, 2025, after market hours, Ardent released its third. ...

Core Viewpoint - Klarna Group plc is facing a class action lawsuit related to its September 10, 2025 IPO, with allegations of misleading offering documents and understated risks regarding loan loss reserves [1][3]. Group 1: Class Action Lawsuit Details - The class action lawsuit, titled Nayak v. Klarna Group plc, allows purchasers of Klarna securities from the IPO to seek lead plaintiff status by February 20, 2026 [1][5]. - Klarna's IPO involved the issuance of approximately 34 million shares at an offering price of $40.00 per share [2]. - The lawsuit claims that Klarna's offering documents were materially false or misleading, particularly regarding the risk of increased loss reserves shortly after the IPO [3]. Group 2: Financial Performance and Stock Impact - Following the IPO, Klarna reported a net loss of $95 million on November 18, 2025, and increased provisions for loan losses to $235 million, exceeding analyst estimates of $215.8 million [4]. - Provisions for loan losses represented 0.72% of gross merchandise volume, up from 0.44% the previous year [4]. - By the time the class action lawsuit commenced, Klarna's stock price had fallen to as low as $31.31 per share, significantly below the IPO price of $40 [4]. Group 3: Legal Representation and Firm Background - Robbins Geller Rudman & Dowd LLP is representing investors in the Klarna class action lawsuit and is recognized as a leading law firm in securities fraud litigation [6]. - The firm has secured over $2.5 billion for investors in securities-related class action cases in 2024, ranking first in monetary relief for investors [6].

Group 1 - The article highlights the upcoming January 12, 2026 deadline for investors to participate as lead plaintiffs in a securities fraud class action lawsuit against Primo Brands Corporation [1] - The lawsuit is on behalf of investors who purchased or acquired common stock of Primo Water Corporation between June 17, 2024, and November 8, 2024, and/or Primo Brands common stock [1]

SAN FRANCISCO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Stride, Inc. (NYSE: LRN) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 12, 2026. The firm urges investors who suffered substantial losses in LRN to contact Hagens Berman now to discuss their rights. The lawsuit seeks to recover investor losses sustained after the purported disclosure of two ...